Published in J Clin Oncol on March 18, 2013
Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol (2013) 5.69
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85
The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Hum Pathol (2011) 1.79
Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics (2012) 1.39
Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer (2010) 1.12
Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol (2010) 1.10
Epratuzumab: targeting B-cell malignancies through CD22. Clin Cancer Res (2003) 0.99
Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol Biomarkers Prev (2013) 0.96
Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl (2014) 0.82
A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements. Semin Liver Dis (2010) 0.77
Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence. Expert Rev Gastroenterol Hepatol (2013) 0.77
Prognostic value of vascular endothelial growth factor levels in patients with hepatocellular carcinoma. J Clin Oncol (2012) 0.75